| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 3 |
| 1 | OMEPRAZOLE | 3 |
| 2 | OMEPRAZOLE MAGNESIUM | 3 |
| 3 | TOCILIZUMAB | 3 |
| 4 | ADALIMUMAB | 2 |
| 5 | AMLODIPINE | 2 |
| 6 | ENZALUTAMIDE | 2 |
| 7 | GABAPENTIN | 2 |
| 8 | INFLIXIMAB | 2 |
| 9 | LANSOPRAZOLE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOTORASIB | 2 | 0.0006 |
| 1 | CEFIXIME | 1 | 0.0003 |
| 2 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 3 | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 5 | ACITRETIN | 1 | 0.0002 |
| 6 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 7 | TOPOTECAN | 1 | 0.0002 |
| 8 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0001 |
| 9 | FESOTERODINE FUMARATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Androgen Receptor Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 7 | Pyridone [EPC] | 1 | 0.0000 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 9 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |